Crossmark

Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases

Crossref DOI link: https://doi.org/10.1016/j.pharep.2014.04.002

Published Print: 2014-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dudarewicz, Michał

Rychlik-Sych, Mariola

Barańska, Małgorzata

Wojtczak, Anna

Trzciński, Radzisław

Dziki, Adam

Skrętkowicz, Jadwiga
License Information

Text and Data Mining valid from 2014-08-01
More Information

This article is maintained by: Elsevier

Article Title: Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2014.04.002

Content Type: article

Copyright: Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.